Sinopep-Allsino Biopharmaceutical Co., Ltd.
FDA inspection history in Lianyungang, China, 2014 to 2016
- 2
- Form 483s
Every document, by year
- Form 483
2014: one Form 483; 2016: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2014–16Two Form 483s, at Lianyungang, China.
- 2014The longest 483 on file: 9 observations over 3 pages at Lianyungang, China.
Cited most
Across all Sinopep-Allsino Biopharmaceutical Co. observations on file
- 21 CFR 211.160General requirements2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.165Testing and release for distribution1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.22Responsibilities of quality control unit1
The complete Sinopep-Allsino Biopharmaceutical Co. file.
All 2 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.
The price of the documents, added to your cart together
Sites
Lianyungang, China
Two Form 483s · 2014 to 2016 · 9 observations
Latest: Form 483, Apr 22, 2016 →
Documents
2 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2016-04-22 | 483 Form 483 | Lianyungang, China | — | $99 |
| 2014-04-11 | 483 Form 483 | Lianyungang, China | 9 | $99 |
Investigators on these documents
FEI number 3005460102 · most recent document Apr 22, 2016
About Sinopep-Allsino Biopharmaceutical Co., Ltd.
How many FDA Form 483s has Sinopep-Allsino Biopharmaceutical Co., Ltd. received?
FDA Intel has 2 Form 483s on file for Sinopep-Allsino Biopharmaceutical Co., Ltd.; the most recent is dated Apr 22, 2016.
When was Sinopep-Allsino Biopharmaceutical Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Sinopep-Allsino Biopharmaceutical Co., Ltd. is a Form 483 dated Apr 22, 2016, for the site in Lianyungang, China.
What did FDA cite at Sinopep-Allsino Biopharmaceutical Co., Ltd.?
The regulations cited most in the observations on file for Sinopep-Allsino Biopharmaceutical Co., Ltd. are 21 CFR 211.160 (General requirements), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.165 (Testing and release for distribution), 1 time.